Athersys to Participate in Three Upcoming Conferences

Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today its participation in three upcoming conferences during the... | May 8, 2023

Related Keywords

Boston ,Massachusetts ,United States ,Washington ,Texas ,American ,Chris Temple ,Sarah Busch ,Head Of Business Development ,Athersys Inc ,Linkedin ,Twitter ,American Thoracic Society ,Facebook ,Nasdaq ,Vice President ,Pharma Manufacturing World Summit ,Allogeneic Cell Therapies Summit ,Regenerative Medicine ,Business Development ,Respiratory Innovation Summit ,Gene Therapy ,Annual Allogeneic Cell Therapies ,Private Securities Litigation Reform Act ,Texas Health Science Center ,Annual Report ,Athersys ,Nc Stock Exchange ,News ,Information ,Press Release ,Regenerative ,Medicine ,Company ,Developing ,Fell ,Therapy ,Or ,Critical ,Mare ,Nnounced ,Oday ,Its ,Participation ,N ,Three ,Pcoming ,Conferences ,Uring Athx Us04744l2051 ,